HHS vs FBYD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

HHS

39.9
AI Score
VS
HHS Wins

FBYD

32.3
AI Score

Investment Advisor Scores

HHS

40score
Recommendation
SELL

FBYD

32score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HHS FBYD Winner
Revenue 75.25M 10.99M HHS
Net Income -5.63M 2.91M FBYD
Net Margin -7.5% 26.5% FBYD
Operating Income -5.26M 6.23M FBYD
ROE -36.7% 19.3% FBYD
ROA -6.4% 4.6% FBYD
Total Assets 88.06M 63.65M HHS
Cash 5.18M 3.09M HHS
Current Ratio 1.30 0.66 HHS
Free Cash Flow -2.95M -361,000 FBYD

Relative Price Performance (Last 90 Days)

HHS 1M: -20.1% · 3M: +59.5% FBYD 1M: +24.0% · 3M: -21.1%

Current Technical Phase

HHS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 24

RSI (14): 23.8 · Price: $3.70

FBYD

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -8.2%) with fading momentum, RSI 49

RSI (14): 49.3 · Price: $8.28

Fundamentals Snapshot

Metric HHS FBYD
Market Cap — —
Forward P/E 3.5 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 1.2%
Gross Margin 0.2% 0.6%
Operating Margin -0.1% -0.8%
EPS -0.77 -0.10
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HHS is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.